Skip to content
ChickenStockChickenStock
ResearchTDOC
Teladoc Health logo

Teladoc Health (TDOC) stock

NYSE

$8.49-2.41%(-0.21)

As of the Nov 17, 2026 close (U.S. Eastern)

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 17, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

-10.05x

Net loss — not comparable

P/B

1.20x

P/S

0.63x

Find stocks with P/B ≤ 0.9×

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Revenue decreased 3.4% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Oct 29, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

28 SEC filings
  • Nueno CarlosPresident, International · Nov 6, 2026Open-market sale29,432 shares · $271K
    Avg. price $9.235,312 shares held after
  • Catapano Joseph RonaldChief Accounting Officer · Oct 2, 2026Open-market sale655 shares · $4K
    Avg. price $5.65314,293 shares held after
  • Catapano Joseph RonaldChief Accounting Officer · Oct 1, 2026Option exercise2,083 shares
    14,948 shares held after
  • DIVITA CHARLES IIICHIEF EXECUTIVE OFFICER · Sep 11, 2026Open-market sale17,805 shares · $109K
    Avg. price $6.104465,535 shares held after
  • DIVITA CHARLES IIICHIEF EXECUTIVE OFFICER · Sep 10, 2026Option exercise42,802 shares
    Show 2 price lots
    • 3,642 sharesValue not reported
    • 39,160 sharesValue not reported
  • Rodrigues Fernando M.President of BetterHelp · Sep 3, 2026Open-market sale9,812 shares · $64K
    Avg. price $6.510 shares held after
  • DIVITA CHARLES IIICHIEF EXECUTIVE OFFICER · Sep 2, 2026Open-market sale18,327 shares · $115K
    Avg. price $6.301440,538 shares held after
  • Vandervoort Adam CCHIEF LEGAL OFFICER, SECRETARY · Sep 2, 2026Open-market sale7,573 shares · $48K
    Avg. price $6.301117,616 shares held after
  • Bliss KellyPresident, U.S. Group Health · Sep 2, 2026Open-market sale7,357 shares · $46K
    Avg. price $6.30192,832 shares held after
  • Nueno CarlosPresident, International · Sep 2, 2026Open-market sale6,200 shares · $39K
    Avg. price $6.30164,744 shares held after
  • Rodrigues Fernando M.President of BetterHelp · Sep 2, 2026Open-market sale5,439 shares · $34K
    Avg. price $6.3019,812 shares held after
  • Catapano Joseph RonaldChief Accounting Officer · Sep 2, 2026Open-market sale274 shares · $2K
    Avg. price $6.30112,865 shares held after
  • Nueno CarlosPresident, International · Sep 1, 2026Option exercise13,273 shares
    Show 2 price lots
    • 4,556 sharesValue not reported
    • 8,717 sharesValue not reported
  • Rodrigues Fernando M.President of BetterHelp · Sep 1, 2026Option exercise15,251 shares
    Show 3 price lots
    • 1,042 sharesValue not reported
    • 8,717 sharesValue not reported
    • 5,492 sharesValue not reported
  • Vandervoort Adam CCHIEF LEGAL OFFICER, SECRETARY · Sep 1, 2026Option exercise14,928 shares
    Show 3 price lots
    • 5,350 sharesValue not reported
    • 9,152 sharesValue not reported
    • 426 sharesValue not reported
  • Bliss KellyPresident, U.S. Group Health · Sep 1, 2026Option exercise15,311 shares
    Show 3 price lots
    • 9,152 sharesValue not reported
    • 4,859 sharesValue not reported
    • 1,300 sharesValue not reported
  • Catapano Joseph RonaldChief Accounting Officer · Sep 1, 2026Option exercise872 shares
    Show 2 price lots
    • 833 sharesValue not reported
    • 39 sharesValue not reported
  • DIVITA CHARLES IIICHIEF EXECUTIVE OFFICER · Sep 1, 2026Option exercise44,243 shares
    Show 2 price lots
    • 42,277 sharesValue not reported
    • 1,966 sharesValue not reported

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Teladoc Health (TDOC) stock information

NYSE

Teladoc Health (TDOC) is listed on NYSE. Its market capitalization is about $1.5B. On trailing-twelve-month earnings the P/E ratio is -10.05, and the P/B ratio is 1.2. Return on equity is -11.9%. These figures are computed in-house from official filings and are reference information only.

Teladoc Health — frequently asked questions

What is the P/E ratio of Teladoc Health (TDOC)?
On a trailing-twelve-month basis, TDOC trades at a P/E ratio of -10.05. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Teladoc Health?
TDOC has a market capitalization of about $1.5B. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.